Thought Leadership Drug Discovery Targets & Screening |

Executive Interview with Peter Sullivan, MyxoTech

On-Demand

July 11, 2025

00:00 UK Time

Event lasts 17m

Peter Sullivan

Chief Executive Officer

MyxoTech

Format: 17 minute interview

Full Video Transcript

Paul Workman Institute of Cancer Research

Rick Ewing Rapafusyn Pharmaceuticals

Zoran Rankovic St. Jude Children’s Research Hospital

Kyle Eastman Halda Therpeutics

Danette Daniels Foghorn Therapeutics

Stefan Schiesser AstraZeneca

Aline Miller University of Manchester

Vasiliki Kalodimou European University-Cyprus – Frankfurt Branch

Maryna Panamarova Wellcome Sanger Institute

Andy Wiranata Wijaya Nestlé

Emma Mead Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford

S Moein Moghimi School of Pharmacy, Newcastle University, UK

Shadi Farhangrazi S. M. Discovery Group (SMDG)

Ralph Minter Alchemab